Editorial: New challenges and future perspectives in pathological conditions

Editorial: New challenges and future perspectives in pathological conditions

Bibliographic Details
Main Authors:	Mustapha Muzaimi, K. N. Bhanu Prakash, Pike See Cheah, Linqing Feng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	alcohol use disorder schizophrenia Angelman syndrome palmitoylethanolamide acupuncture CIBP
Online Access:	https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1201044/full

Similar Items

A Mouse Model of Cancer Induced Bone Pain: From Pain to Movement
by: Haiwang Ji, et al.
Published: (2022-06-01)

Aconitine – A promising candidate for treating cold and mechanical allodynia in cancer induced bone pain
by: Xiang Jin, et al.
Published: (2023-05-01)

Angelman syndrome /
by: 276325 Dan, Bernard
Published: (2008)

Craniofacial disorders in the course of Angelman syndrome - a review of the literature
by: Katarzyna Brukiewicz, et al.
Published: (2020-06-01)

Синдром Ангельмана. Часть 1 (этиология и патогенез)
by: A.Ye. Abaturov, et al.
Published: (2015-08-01)

Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome
by: Robert P. Carson, et al.
Published: (2019-09-01)

The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection—A Double Blind, Randomised, Placebo-Controlled Trial
by: Amanda Rao, et al.
Published: (2023-10-01)

Short-term efficacy of a fixed association of Palmitoylethanolamide and other phytochemicals as add-on therapy in the management of chronic pain in elderly patients: a real-world retrospective study
by: Walter Gianni, et al.
Published: (2018-05-01)

Do the diverse phenotypes of Prader-Willi syndrome reflect extremes of covariation in typical populations?
by: Iiro Salminen, et al.
Published: (2022-11-01)

A randomised controlled trial assessing the potential of palmitoylethanolamide (PEA) to act as an adjuvant to resistance training in healthy adults: a study protocol
by: Zoya Huschtscha, et al.
Published: (2023-03-01)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
by: Amanda Rao, et al.
Published: (2021-09-01)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018-03-01)

Co-micronized palmitoylethanolamide/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically-induced endometriosis
by: Rosanna Di Paola, et al.
Published: (2016-10-01)

Surgical extraction of a supernumerary tooth in a patient with Angelman syndrome - case report
by: Małgorzata Lipczyńska-Lewandowska, et al.
Published: (2020-07-01)

A Meta-Analysis on the Efficacy of Acupuncture as an Adjuvant Therapy for Schizophrenia
by: Huang C, et al.
Published: (2023-11-01)

Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials
by: Martina D’Angelo, et al.
Published: (2024-03-01)

Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator
by: Maria Clara Inácio de Sá, et al.
Published: (2023-12-01)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
by: Rosalba Siracusa, et al.
Published: (2020-10-01)

Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat
by: Alessio Filippo Peritore, et al.
Published: (2020-05-01)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
by: Ramona D’Amico, et al.
Published: (2020-07-01)

Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation
by: Giovanna Casili, et al.
Published: (2020-10-01)

Antioxidant and Anti-Inflammatory Activity of Combined Phycocyanin and Palmitoylethanolamide in Human Lung and Prostate Epithelial Cells
by: Loredana Bergandi, et al.
Published: (2022-01-01)

Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?
by: Hesselink JMK, et al.
Published: (2016-09-01)

Focus on the Endogenous Cannabinoid System in Migraine
by: Domenico Chirchiglia, et al.
Published: (2017-08-01)

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion
by: Daniela Impellizzeri, et al.
Published: (2019-05-01)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
by: Lucas D. Udovin, et al.
Published: (2020-01-01)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
by: Alshelh Z, et al.
Published: (2019-08-01)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
by: Chirchiglia D, et al.
Published: (2016-07-01)

Fatty Acid Amides Synthesized from Andiroba Oil (<i>Carapa guianensis</i> Aublet.) Exhibit Anticonvulsant Action with Modulation on GABA-A Receptor in Mice: A Putative Therapeutic Option
by: Fábio Rodrigues de Oliveira, et al.
Published: (2020-03-01)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
by: Chirchiglia D, et al.
Published: (2019-02-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

Angelman Syndrome
by: Daniela Abigail Cobo-Álvarez, et al.
Published: (2022-12-01)

Análise comparativa entre as metodologias de PCR metilação-específica (MSP), Southern blot (SB) e FISH utilizadas no diagnóstico genético molecular de pacientes com suspeita clínica das síndromes de Prader-Willi ou Angelman
by: Bruna Oliveira, et al.
Published: (2016-08-01)

Paradoxical Hyperexcitability in Disorders of Neurodevelopment
by: Michelle W. Antoine
Published: (2022-04-01)

Análise comparativa entre as metodologias de PCR metilação-específica (MSP), Southern blot (SB) e FISH utilizadas no diagnóstico genético molecular de pacientes com suspeita clínica das síndromes de Prader-Willi ou Angelman
by: Bruna Oliveira, et al.
Published: (2016-08-01)

Angelman Syndrome and Angelman-like Syndromes Share the Same Calcium-Related Gene Signatures
by: Julia Panov, et al.
Published: (2021-09-01)

Síndrome de Angelman Angelman Syndrome
by: Lázara Caridad Faife Abril, et al.
Published: (2012-09-01)

Síndrome de Angelman: causa frequentemente não reconhecida de deficiência mental e epilepsia. relato de caso Angelman syndrome: a frequently undiagnosed cause of mental retardation and epilepsy. case report
by: Cintia Fridman, et al.
Published: (1997-06-01)

Management of Traumatic Brain Injury: From Present to Future
by: Rosalia Crupi, et al.
Published: (2020-04-01)